MCL-1 is a prognostic indicator and drug target in breast cancer-Reference-Cited by-同舟云学术

MCL-1 is a prognostic indicator and drug target in breast cancer

Published:2018-01-16 Issue:2 Volume:9 Page:
ISSN:2041-4889
Container-title:Cell Death & Disease
language:en
Short-container-title:Cell Death Dis

Author:

Campbell Kirsteen J.^ORCID,Dhayade Sandeep,Ferrari Nicola,Sims Andrew H.,Johnson Emma,Mason Susan M.,Dickson Ashley,Ryan Kevin M.,Kalna Gabriela,Edwards Joanne,Tait Stephen W. G.,Blyth Karen^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Cell Biology,Cellular and Molecular Neuroscience,Immunology

Link

http://www.nature.com/articles/s41419-017-0035-2.pdf

Reference56 articles.

1. Torre, L. A., Siegel, R. L., Ward, E. M. & Jemal, A. Global cancer incidence and mortality rates and trends—an update. Cancer Epidemiol. 25, 16–27 (2016).

2. Lopez, J. et al. Mito-priming as a method to engineer Bcl-2 addiction. Nature Commun. 7, 10538 (2016).

3. Kelly, G. L. & Strasser, A. The essential role of evasion from cell death in cancer. Adv. Cancer Res. 111, 39–96 (2011).

4. Cory, S., Roberts, A. W., Colman, P. M. & Adams, J. M. Targeting BCL-2-like proteins to kill cancer cells. Trends Cancer. 2, 443–460 (2016).

5. Souers, A. J. et al. ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets. Nat. Med. 19, 202–208 (2013).

Cited by 149 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting overexpressed surface proteins: A new strategy to manage the recalcitrant triple-negative breast cancer;European Journal of Pharmacology;2024-10

2. BRD-810 is a highly selective MCL1 inhibitor with optimized in vivo clearance and robust efficacy in solid and hematological tumor models;Nature Cancer;2024-08-23

3. Discovery of Novel Mcl-1 Inhibitors with a 3-Substituted-1H-indole-1-yl Moiety Binding to the P1–P3 Pockets to Induce Apoptosis in Acute Myeloid Leukemia Cells;Journal of Medicinal Chemistry;2024-08-09

4. Discovery of a Myeloid Cell Leukemia 1 (Mcl-1) Inhibitor That Demonstrates Potent In Vivo Activities in Mouse Models of Hematological and Solid Tumors;Journal of Medicinal Chemistry;2024-08-05

5. Evaluation of MCL-1 as a prognostic factor in canine mammary gland tumors;PLOS ONE;2024-07-16